Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Lung Neoplasms 3Peripheral Nervous System Diseases 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Multiple Myeloma 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Infections 1

Interventions

fludarabine 4Cyclophosphamide 4Specimen Handling 2Nivolumab 2Natalizumab 2Interferon beta-1b 2Fingolimod Hydrochloride 2Blood Specimen Collection 2teriflunomide 1nabiximols 1gadobutrol 1gadobenic acid 1cabozantinib 1Surveys and Questionnaires 1Respiratory Therapy 1Registries 1Platinum Compounds 1Platelet Transfusion 1Plasma Exchange 1Phlebotomy 1OM 89 1Mn-PyC3A 1Medical Marijuana 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Ipilimumab 1Interferon beta-1a 1Injections 1Gadolinium DTPA 1Fish Oils 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Sclerosis × Fish Oils × Clear all
NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Isfahan University of Medical Sciences

Phase 2/3 Completed
50 enrolled 20 charts

Multiple Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡